Abhelfen Life Science Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 4 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 26.10 Cr
- Revenue Growth -51.80%
- Profit Growth -70.35%
- Ebitda -97.09%
- Net Worth 14059.11%
- Total Assets 163.25%
About Abhelfen Life Science
Abhelfen Life Science Private Limited (ALSPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 June 2020 (Four years and eight months 8 days old ). Its registered office is in Gandhi Nagar, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹26.10 Cr.
Amrut Chaudhari, Mukeshkumar Soni, Nileshkumar Mehta, and One other member serve as directors at the Company.
Company Details
- Location
Gandhi Nagar, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230GJ2020PTC113956
- Company No.
113956
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jun 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Abhelfen Life Science?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amrut Chaudhari  | Director | 14-Jun-2020 | Current |
| Mukeshkumar Soni | Director | 14-Jun-2020 | Current |
| Nileshkumar Mehta | Director | 01-May-2024 | Current |
| Padma Parmar | Director | 14-Jun-2020 | Current |
Financial Performance of Abhelfen Life Science.
Abhelfen Life Science Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 51.8% decrease. The company also saw a substantial fall in profitability, with a 70.35% decrease in profit. The company's net worth Soared by an impressive increase of 14059.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Abhelfen Life Science?
Unlock access to Abhelfen Life Science's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Abhilasha Pharma Private LimitedAmrut Chaudhari and Mukeshkumar Soni are mutual person
Alma Life Science Private LimitedAmrut Chaudhari and Nileshkumar Mehta are mutual person
Ambica Pharmachem Private LimitedAmrut Chaudhari is a mutual person
- Rangodadhi Chemicals Private Limited
Amrut Chaudhari is a mutual person
- Aukea Life Sciences Private Limited
Amrut Chaudhari and Mukeshkumar Soni are mutual person
Charges (Loans)
₹261.00 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 26.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 May 2023 | Hdfc Bank Limited | ₹1.00 M | Open |
| 27 Oct 2021 | Hdfc Bank Limited | ₹26.00 Cr | Open |
How Many Employees Work at Abhelfen Life Science?
Abhelfen Life Science has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Abhelfen Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abhelfen Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
